A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia

被引：0
|
作者：
Saleh, MN
Gutheil, J
Moore, M
Bunch, PW
Butler, J
Kunkel, L
Grillo-López, AJ
LoBuglio, AF
机构：
[1] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[2] Genentech Inc, S San Francisco, CA 94080 USA
[3] Georgia Canc Specialists, Atlanta, GA USA
[4] Sidney Kimmel Canc Ctr, San Diego, CA USA
[5] IDEC Pharmaceut Corp, San Diego, CA USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：99 / 103
页数：5
相关论文
共 50 条
  • [1] The use of anti-CD20 chimeric monoclonal antibody, rituximab in adult patients with treatment refractory immune thrombocytopenia
    Jacoub, J
    Mchlayeh, W
    Tabbara, I
    Dave, HP
    Siegel, R
    Schechter, GP
    BLOOD, 2004, 104 (11) : 74B - 74B
  • [2] Treatment of thrombocytopenia in refractory Evan's syndrome with anti-CD20 monoclonal antibody (Rituximab).
    Baltathakis, I
    Kakkas, I
    Karkatitaris, C
    Papasavvas, PL
    Tsionos, K
    BLOOD, 2002, 100 (11) : 82B - 82B
  • [3] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [4] Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus
    ten Cate, R
    Smiers, FJ
    Bredius, RGM
    Lankester, AC
    van Suijlekom-Smit, LWA
    Huizinga, TW
    Egeler, RM
    RHEUMATOLOGY, 2004, 43 (02) : 244 - 245
  • [5] EFFECT OF ANTI-CD20 MONOCLONAL ANTIBODY (RITUXIMAB) IN IMMUNE THROMBOCYTOPENIA. EXPERIENCE IN A PERUVIAN HOSPITAL
    Untama, J. L.
    Del Carpio, D.
    Navarro, J.
    HAEMATOLOGICA, 2012, 97 : 687 - 687
  • [6] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
  • [7] Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
    Dupuy, A
    Viguier, M
    Bédane, C
    Cordoliani, F
    Blaise, S
    Aucouturier, F
    Bonnetblanc, JM
    Morel, P
    Dubertret, L
    Bachelez, H
    ARCHIVES OF DERMATOLOGY, 2004, 140 (01) : 91 - 96
  • [8] A pilot study of anti-CD20 MoAb Rituximab in patients with refractory immune thrombocytopenic purpura (ITP).
    Saleh, MN
    Gutheil, J
    Moore, M
    Feinberg, B
    Bunch, P
    Butler, J
    Lavelle, P
    Kunkel, L
    Benyunes, K
    Grillo-Lopez, A
    LoBuglio, A
    BLOOD, 2000, 96 (11) : 252A - 253A
  • [9] A pilot study of anti-CD20 MoAb rituximab in patients with refractory immune thrombocytopenic purpura (ITP).
    Saleh, MN
    Moore, M
    Feinberg, B
    Bunch, P
    Butler, J
    Lavelle, P
    Kunkel, L
    Benyunes, K
    Grillo-Lopez, A
    LoBuglio, AF
    BLOOD, 2001, 98 (11) : 521A - 521A
  • [10] Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab
    Weitz, IC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (02) : 138 - 141
12345